Longitudinal Study for Central Nervous System Vasculitis

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
University of Pennsylvania
Study ID
NCT05734404
Status
Recruiting
Apply to this trial

Conditions

  • CNS Vasculitis
  • CNSV
  • Central Nervous System Vasculitis
  • Vasculitis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

Primary central nervous system vasculitis (CNSV) is a potentially fatal, single-organ vasculitis that often involves a spectrum of neurologic complications, including strokes, cognitive and speech impairment, visual loss, dementia, and encephalopathy. The purpose of this study is to establish a research cohort to investigate the disease process, treatments, and patient outcomes in CNSV.

Key Dates

Start date
Mar 1, 2023
Status verified
Jan 2026
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
40 participants (estimated)

Primary Outcome Measure

Evaluate the pathogenesis of central nervous system vasculitis using disease history. [ Time Frame: Study completion; from baseline through month 36. ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55905
Jenni Sletten
[email protected]
Cleveland ClinicClevelandOhio44195
Brittany McKnight
[email protected]
University of PennsylvaniaPhiladelphiaPennsylvania19104
Jessica Nguyen
[email protected]
Vanderbilt UniversityNashvilleTennessee37232
Pamela Schlairet
[email protected]

Find similar trials in Rochester, MN

By research site
Mayo Clinic· Rochester, MNCleveland Clinic· Cleveland, OHUniversity of Pennsylvania· Philadelphia, PAVanderbilt University· Nashville, TN

Related Studies